Ryght start

From final protocol to first-patient-in

One partner for site selection, feasibility, contracts, approvals and site initiation, in every country.  

01 · Ryght
Site Identification
Ranked list in under 24 hours
02 · Ryght
Feasibility
PI says yes and the startup clock starts
03 · Ryght
Activation
Contracts, approvals, supply
04 · Ryght
Site screening
Green light and SIV
05 · Your partner
Study conduct
Your CRO or conduct partner

Activate clinical trial sites sooner with AI-powered study startup

Ryght brings site intelligence, feasibility and activation together, with AI-native dashboards to track every startup process across every site and country.

Modeled Phase 3 study startup timeline. With Ryght, first patient in is at week 20 versus week 26 for the industry baseline, and 75% of sites are active at week 34 versus week 48. The model includes roadmap capabilities.
Select the image to view the full-size timeline in a new tab.

Illustrative global Phase 3 oncology model across 30 countries, approximately 200 sites and 600 patients. Timelines are measured from final protocol and include roadmap capabilities. The 18-month figure represents a client-reported worst case for the slowest academic sites, not the industry baseline. Actual timelines vary.

The activation method

A rapid, coordinated approach to site activation across every country

A · Select and confirm
01 Site identification
02 Feasibility
03 CDA and NDA execution
04 Site confirmation
B · Contract and approve
05 Budget and CTA negotiation
06 Insurance and indemnity
07 Informed consent
08 Regulatory documents
09 IRB and ethics approval
10 Health authority filings
C · Supply and go
11 Import and export permits
12 Drug supply and central lab
13 Site initiation visit
What you receive with every activation
Country Activation Brief
Site Activation Tracker
Regulatory and ethics submission package
CTA and budget pack
Essential document binder (eTMF)
Green-light checklist
What Ryght does differently

Select the right sites and activate them fast

Real capacity
Sites chosen from their AI Site Twin, on current capacity and performance, not on who a CRO already knows.
Template budgets
Budgets built against fair market value and ready to submit on day one.
Master agreements
Agreements held at the site level, plus national templates such as the NHS model CTA.
Scored partners
In-country regulatory and site activation partners, rated on real cycle time, quality and cost.
Plan your study startup

See how your study gets from protocol to active sites

Share your synopsis. Get a ranked site list and a startup plan.

Plan your study startup
Illustration of connected clinical trial sites across the globe
Commercial model

You pay for the startup. Everything else passes through at cost

We compete on the startup services fee. Ethics, lab, drug supply and filing fees pass through at zero markup. Our target is a startup cost per site 30% below the $20K to $75K per site that a full-service CRO charges.

Who runs it
VP of Clinical Operations 
Country-specific requirements

Every country has its own rules. Ryght runs them all

Last verified September 2026
United Kingdom
One combined MHRA and ethics review. One REC opinion covers every UK site. The NHS model CTA shortens contracts.
New regulations in force since 28 April 2026. Government target: 150 days to set up a commercial trial.
Australia
The ethics committee is the gate. The CTN is a notification to the TGA, and recruiting does not wait for its acknowledgement.
A named Australian sponsor is required. The Medicines Australia CTRA template shortens contracts.
European Union
One CTIS application covers every member state in the trial. Ryght picks the reporting member state from Site Twin data.
The FAST-EU pilot targets 70 days or less from submission to decision for eligible multinational trials.
Questions

What sponsors ask first

Is Ryght a CRO?

No. Ryght manages study start-up. Once sites begin screening patients, your CRO or study conduct partner takes over.

Can we use Ryght with our CRO?

Yes, but start with Ryght. Ryght identifies the best geographies and sites first, then helps you choose the right CRO for that footprint, if you need one. No CRO? Ryght partners with technology companies for monitoring and study management.

Who signs the contracts?

You do. Your team keeps negotiation limits, legal approval and final signature. Ryght drafts, checks and routes.

What if a site stalls?

Every site runs on one tracker with an owner and a date per step. A stalled site is escalated or replaced from the ranked list.

What does it cost?

A startup services fee per site. Pass-through costs stay at cost.

Send a synopsis. Get a site list and a startup plan

We return a ranked site and country list in under 24 hours, with a startup timeline built for your protocol.